Terms: = Bone cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Prognosis
21 results:
1. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
[No Abstract] [Full Text] [Related]
2. cancer-Associated Exosomal cbfb Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to bone Prometastatic Factor of Breast cancer Progression.
Hsu CH; Ma HP; Ong JR; Hsieh MS; Yadav VK; Yeh CT; Chao TY; Lee WH; Huang WC; Kuo KT; Fong IH; Lin CC; Su CM
Dis Markers; 2022; 2022():8446629. PubMed ID: 35903297
[TBL] [Abstract] [Full Text] [Related]
3. AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.
Assaf N; Lefebvre C; Raggueneau V; Guignedoux G; Marceau-Renaut A; Chevalier S; Tondeur S; Bories D; Benramdane R; Rousselot P; Terré C
Hematology; 2022 Dec; 27(1):636-641. PubMed ID: 35622005
[TBL] [Abstract] [Full Text] [Related]
4. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/cbfb-MYH11 acute myeloid leukemia.
Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
[TBL] [Abstract] [Full Text] [Related]
5. CSF3R Mutations are frequently associated with abnormalities of RUNX1, cbfb, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract] [Full Text] [Related]
6. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
[TBL] [Abstract] [Full Text] [Related]
7. Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma.
Kim SH; Shin KH; Moon SH; Kong Y; Suh JS; Yang WI
J Surg Oncol; 2017 May; 115(6):752-759. PubMed ID: 28403564
[TBL] [Abstract] [Full Text] [Related]
8. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A bone Marrow Pathology Group Multicenter Study.
Rogers HJ; Hsi ED; Tang G; Wang SA; Bueso-Ramos CE; Lubin D; Morrissette JJ; Bagg A; Cherukuri DP; George TI; Peterson L; Liu YC; Mathew S; Orazi A; Hasserjian RP
Am J Clin Pathol; 2017 Apr; 147(4):411-419. PubMed ID: 28375434
[TBL] [Abstract] [Full Text] [Related]
9. Myeloid neoplasms with concurrent BCR-ABL1 and cbfb rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract] [Full Text] [Related]
10. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
[TBL] [Abstract] [Full Text] [Related]
11. [The hematological malignancies related to primary hypereosinophilia and their diagnostics].
Skonieczka K; Matiakowska K; Haus O
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1530-7. PubMed ID: 25834096
[TBL] [Abstract] [Full Text] [Related]
12. Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.
Dawson AJ; Bal S; McTavish B; Tomiuk M; Schroedter I; Ahsanuddin AN; Seftel MD; Vallente R; Mai S; Cotter PD; Hovanes K; Gorre M; Gunn SR
Cancer Genet; 2011 Jun; 204(6):344-7. PubMed ID: 21763633
[TBL] [Abstract] [Full Text] [Related]
13. Incidence and prognostic importance of molecular genetic defects in children with acute myeloblastic leukemia.
Kömür M; Erbey F; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2010; 11(5):1393-5. PubMed ID: 21198299
[TBL] [Abstract] [Full Text] [Related]
14. Ki-67 immuno-histochemistry index in stage III giant cell tumor of the bone.
Ismail FW; Shamsudin AM; Wan Z; Daud SM; Samarendra MS
J Exp Clin Cancer Res; 2010 Mar; 29(1):25. PubMed ID: 20226047
[TBL] [Abstract] [Full Text] [Related]
15. Detection of a novel cbfb/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of cbfb gene using two commercially available multiplex RT-PCR kits.
Park TS; Lee ST; Song J; Lee KA; Lee JH; Kim J; Lee HJ; Han JH; Kim JK; Cho SR; Choi JR
Cancer Genet Cytogenet; 2009 Mar; 189(2):87-92. PubMed ID: 19215788
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical analysis of 34 cases of esthesioneuroblastoma].
Liu WS; Tang PZ; Xu GZ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
[TBL] [Abstract] [Full Text] [Related]
17. Deletion of cbfb in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16.
Egan N; O'Reilly J; Chipper L; Higgins M; Herrmann R; Cannell P
Cancer Genet Cytogenet; 2004 Oct; 154(1):60-2. PubMed ID: 15381374
[TBL] [Abstract] [Full Text] [Related]
18. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis.
Kolomietz E; Al-Maghrabi J; Brennan S; Karaskova J; Minkin S; Lipton J; Squire JA
Blood; 2001 Jun; 97(11):3581-8. PubMed ID: 11369654
[TBL] [Abstract] [Full Text] [Related]
19. [The genetic diagnosis of hematopoietic malignancy by polymerase chain reaction method].
Yokota H; Kitamura K
Rinsho Byori; 2000 Aug; 48(8):708-15. PubMed ID: 11064593
[TBL] [Abstract] [Full Text] [Related]
20. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.
Martinez-Climent JA; Comes AM; Vizcarra E; Reshmi S; Benet I; Marugan I; Tormo M; Terol MJ; Solano C; Arbona C; Prosper F; Barragan E; Bolufer P; Rowley JD; García-Conde J
Cancer Genet Cytogenet; 1999 Apr; 110(2):111-4. PubMed ID: 10214358
[TBL] [Abstract] [Full Text] [Related]
[Next]
